Mapping Noncovalent Ligand Binding to Stemloop Domains of the HIV-1 Packaging Signal by Tandem Mass Spectrometry  by Turner, Kevin B. et al.
FOCUS: NUCLEIC ACIDS IN MASS SPECTROMETRY
Mapping Noncovalent Ligand Binding
to Stemloop Domains of the HIV-1 Packaging
Signal by Tandem Mass Spectrometry
Kevin B. Turner, Nathan A. Hagan, Andrew S. Kohlway,
and Daniele Fabris
Department of Chemistry and Biochemistry, University of Maryland Baltimore County,
Baltimore, Maryland, USA
The binding modes and structural determinants of the noncovalent complexes formed by
aminoglycoside antibiotics with conserved domains of the HIV-1 packaging signal (-RNA) were
investigated using electrospray ionization (ESI) Fourier transformmass spectrometry (FTMS). The
location of the aminoglycoside binding sites on the different stemloop structures was revealed by
characteristic coverage gaps in the ion series obtained by sustained off-resonance irradiation
collision induced dissociation (SORI-CID) of the antibiotic-RNA assemblies. The site positions
were confirmed using mutants that eliminated salient structural features of the -RNA domains.
The effects of the mutations on the binding properties of the different substrates served to validate
the position of the aminoglycoside site on the wild-type structures. Additional information was
provided by docking experiments performed on the different aminoglycoside-stemloop com-
plexes. The results have shown that, in the absence of features disrupting the regular A-helix of the
double-stranded stem, aminoglycosides tend to bind in an area situated between the upper stem
and the loop regions, as demonstrated for stemloop SL3. The presence of a tandem wobbles motif
in SL4 modifies the regular geometry of the upper stem, which does not affect the general site
location, but greatly increases its solution binding affinity compared with SL3. The platform motif
in SL2 locates the binding site in the stem midsection and confers upon this stemloop an
intermediate affinity toward aminoglycosides. In SL3 and SL4, the extensive overlap of the
antibiotic site with the region used to bind the nucleocapsid (NC) protein provides the basis for a
competition mechanism that could explain the aminoglycoside inhibition of the NC·SL3 and
NC·SL4 assemblies. In contrast, the minimal overlap between the aminoglycoside and the NC sites
in SL2 accounts for the absence of inhibition of the NC·SL2 complex. (J Am Soc Mass Spectrom
2006, 17, 1401–1411) © 2006 American Society for Mass SpectrometryDuring the replication of human immunodefi-ciency virus type 1 (HIV-1), specific interactionsbetween the packaging signal () [1–3] of viral
RNA and the nucleocapsid (NC) [4, 5] domain of the
Gag polyprotein mediate the vital functions of genome
recognition, dimerization and packaging [6]. The rela-
tively low mutation frequency of this 120 nt stretch of
genomic RNAmakes the packaging signal a very prom-
ising target for the development of new therapeutic
strategies to contend with the rapid emergence of drug
resistant strains [7, 8]. For this reason, steps have been
made toward the identification of possible inhibitors
that may bind specific -RNA structures and disrupt
their normal functions [9 –11]. In a systematic investi-
gation of classic nucleic acid ligands, we have recently
Published online July 26, 2006
Address reprint requests to Dr. D. Fabris, Department of Chemistry and
Biochemistry, University of Maryland Baltimore County, 100 Hilltop Circle,
Baltimore, MD 21228, USA. E-mail: fabris@umbc.edu
© 2006 American Society for Mass Spectrometry. Published by Elsevie
1044-0305/06/$32.00
doi:10.1016/j.jasms.2006.06.009shown that aminoglycosidic antibiotics are not only
capable of binding individual domains of -RNA, but
can also inhibit their interactions with NC in a struc-
ture-specific fashion [12]. Initial tests to locate the actual
binding sites on the different RNA substrates, which is
crucial to explain the mechanism of preferential inhibi-
tion, were based on the analysis of mutant-ligand
complexes performed by electrospray ionization (ESI)
[13, 14] and Fourier transform mass spectrometry
(FTMS) [15, 16].
The favorable energetics characteristic of ESI enable
the analysis of relatively labile noncovalent complexes
by mass spectrometry [17–19] and offer the possibility
of obtaining valuable information about specific pro-
tein–nucleic acid, nucleic acid–nucleic acid, and small
ligand–nucleic acid interactions (reviewed in [20] and
[21]). The binding selectivity and the stoichiometry of
noncovalent complexes formed by DNA [22–28] and
RNA [29 –32] substrates with a variety of small organic
molecules can be determined unambiguously from di-
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of bulk data provided by spectroscopic and calorimetric
methods. Relative and absolute binding affinities are
readily attainable by strategies that rely on the ability of
ESI-MS to resolve complexes with very close physical-
chemical characteristics, which are not easily discrimi-
nated by other established techniques. Competitive
binding experiments have been implemented in which
multiple ligands are mixed simultaneously with a target
substrate to form a distribution of complexes with
abundances reflecting the respective binding affinities
[33–37]. Rigorous quantitative determinations of disso-
ciation constants (Kds) have been obtained from titra-
tion experiments in which the abundance of free versus
bound species in solution was monitored by ESI-MS
after each addition of ligand [12, 38 – 41].
Tandem mass spectrometry has been extensively
used to identify the sequence of oligonucleotide sam-
ples [42– 46] and characterize their covalent modifica-
tions [47–51] based on characteristic ions series pro-
duced by fragmentation of the nucleic acid backbone. In
contrast, gas-phase activation of small ligand-nucleic
acid complexes has been more actively pursued to
investigate their stability rather than to map the actual
binding sites [52–56]. Characteristic dissociation pat-
terns obtained from these precursor ions have been
effectively correlated to the nature and selectivity of the
binding interaction. In complexes formed by minor
groove binders with duplex DNA oligonucleotides, the
direct dissociation of the small molecule was found to
be less favorable than the unzipping of the complemen-
tary strands [52, 53] and the partial fragmentation of
their covalent backbone [54]. In complexes involving
DNA quadruplex structures, the contrast between
strand disassembly and ligand dissociation served to
clearly differentiate the binding modes presented by the
groove-binder distamycin and the perylene-diimide an-
alog Tel01 [55].
Targeted fragmentation of the phosphodiester back-
bone has been previously utilized to screen members of
combinatorial libraries for their ability to bind specific
targets [38, 57]. Based on the observation that RNA and
2=-O-methyl RNA undergo fragmentation 5 to 10 times
less efficiently than DNA [58], a chimeric 2=-O-methyl-
ribonucleotide corresponding to the bacterial rRNA
A-site was synthesized with deoxyadenine mutations
located in selected sequence positions to induce facile
gas-phase cleavage. The inhibitory effects exerted by
ligand interactions on the dissociation of these key
deoxynucleotides were subsequently evaluated to iden-
tify the candidates that provided specific binding to the
desired site(s) [57].
In this report, we have explored the possibility of
employing sustained off-resonance irradiation collision
induced dissociation (SORI-CID) [59] to map the actual
binding sites of aminoglycosidic antibiotics on individual
stemloop domains of -RNA. The validity of the maps
provided by the sequencing experiments was tested using
mutant substrates in which the putative sites were modi-fied to reduce or eliminate their ability to bind the ligand,
rather than to direct the gas-phase fragmentation pro-
cesses. Docking experiments were also carried out to test
whether the regionsmapped by SORI-CIDwould actually
present favorable characteristics to support the ligand
interaction. In an effort to explain the selective inhibitory
effects induced by aminoglycosides on the different NC-
stemloop complexes, the binding determinants and the
locations of the ligand sites have been discussed in the
context of the unique structural features presented by the
target RNA stemloops.
Experimental
Materials and Methods
Oligo-ribonucleotides matching the sequences of SL2,
SL3, and SL4 from the NL4-3 strain of HIV-1 and their
respective mutants (Scheme 1) were purchased from
IDT (Coralville, IA). Three additional base pairs were
included at the base of the SL4 stem to stabilize its
secondary structure. The SL3 duplex (SL3D) was ob-
tained by heat-annealing two individual oligo-ribo-
nucleotides replicating the complementary strands of
the SL3 stem. Two GC pairs were added at the ends to
increase the stability of the double-stranded structure
and match the total number of 20 nucleotides present in
the template stemloop construct (Scheme 1).
Each sample was extensively desalted by ultrafiltra-
tion on Centricon YM-3 devices (Millipore, Bedford,
MA) using a 100 mM solution of ammonium acetate
(pH 7.5). The purity and integrity of each sample were
confirmed by ESI-FTMS. The concentration of each
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Scheme 1. Sequence and secondary structures of individual
stemloops of HIV-1 -RNA and selected mutants. The letter “d”
indicates abasic phosphodeoxyribose spacers. Highlighted in red
are the regions identified by tandem mass spectrometry. In gray
are the extra GC pairs added to stabilize the SL3D duplex structure
(see the Experimental section).stock solution was determined by UV absorbance, using
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mM1 cm1 for SL2, 201.99 mM1 cm1 for SL3, and
201.99 mM1 cm1 for SL4. Immediately before use,
each construct was heated to 95 °C for 3 min and
quickly cooled on ice to achieve proper folding of the
hairpin structures.
Neomycin B, paromomycin, tobramycin, ethidium
bromide, and distamycin A (Scheme 2) were purchased
from Sigma Chemical Co. (St. Louis, MO) and utilized
without further purification. Stock solutions were pre-
pared by dissolving weighed amounts of dry material
in 100 L of a 100 mM solution of ammonium acetate
(pH 7.5).
The desired ligand-RNA complexes were assembled
by mixing appropriate volumes of the respective stock
solutions in 100 mM ammonium acetate (pH 7.5),
followed by 15 min incubation at room temperature to
ensure proper binding. Typical samples consisted of 10
L solutions containing 3.5 M RNA. Competitive
binding experiments were carried out by mixing
equimolar amounts (3.5 M each) of wild-type and
mutant RNA substrates in 100 mM ammonium acetate
(pH 7.5). Appropriate volumes of ligand stocks were
added to the substrate mixtures to obtain the desired
final concentrations, followed by 15 min incubation at
room temperature to allow for the multiple binding
equilibria to be established. Control experiments per-
formed with longer incubation provided no detectable
binding differences.
Mass Spectrometry
Appropriate volumes of isopropanol were added to
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Scheme 2. Structures of nucleic acid ligands em
and R  OH paromomycin (PR); (b) tobramyci
(DA).each sample immediately before analysis to achieve afinal 9:1 ratio of aqueous to organic phase. Each nano-
electrospray determination required loading  5 L
analyte solution into an uncoated borosilicate needle
with a stainless steel wire inserted from the back end to
provide the necessary voltage. All analyses were carried
out in negative ion mode on a Bruker Daltonics (Bil-
lerica, MA) Apex III 7.0T Fourier transform mass spec-
trometer equipped with a heated metal desolvation
capillary, which was kept at 120 to 150 °C. In tandem
experiments, the precursor ion of interest was isolated
in the FTMS cell using correlated rf sweeps (CHEF) [60],
followed by activation through sustained off-resonance
irradiation (SORI) [59]. Frequency offsets below and
above the resonant frequency of the precursor ion were
sampled to avoid possible “blind spots” in the product
spectra [61]. Best results were achieved by using irradi-
ation frequencies that were 600 to 2000 Hz below that of
the precursor ion. Off-resonant pulses were typically
applied for 250 msec using a 22 to 25 dB attenuation of
the maximum power output allowed by the hardware,
but lower power experiments were also performed
using up to 26 to 31 dB attenuation. Argon was used as
the collision gas in pulsed bursts of 100 to 250 ms, which
resulted in momentary increases from 1  1011 to 1 
107 mbar of the background pressure measured by the
instrument gauge located underneath the ion optics. No
attempt was made to determine the actual pressure in
the vicinity of the FTMS cell. Twenty-five to fifty scans
were typically averaged for each spectrum. All data
were acquired in broadband mode and were processed
using XMASS 7.0.8 (Bruker). Data reduction and anal-
ysis were performed with the aid of MS2Links [51] and
3
N
H
O
N
CH3
N
H
O
N
CH3
N
H
NH2
O NH
O O
O
OO
NH2
OH
NH2
OH
N2
OH
NH2
NH2OHH2N
)b
)d
ed in the study: (a) R  NH2 neomycin B (NB)
); (c) ethidium bromide (ET); (d) distamycin AN
CH
H
ploy
n (TBthe Mongo Oligo Mass Calculator version 2.05 made
1404 TURNER ET AL. J Am Soc Mass Spectrom 2006, 17, 1401–1411available by Dr. J. McCloskey at http://medlib.med.u-
tah.edu/masspec/.
Docking Calculations
Docking simulations were performed using Autodock
3.0, with additional help from the Autodocktools pack-
age [62]. Neomycin B was docked into each stemloop
(PDB:1ESY for SL2, PDB:1BN0 for SL3, and PDB:1JTW
for SL4) using the Lamarckian genetic algorithm (LGA).
A total of 50 docked structures for each stem loop were
generated, 10 at a time, using varying grid sizes ranging
from 90 90 90 to 126 126 126 and a grid spacing
of 0.150 to 0.375 Å. Typical settings employed for this
procedure include a population size of 150, a maximum
number of 250,000 energy evaluations, a maximum
number of 27,000 generations, a mutation rate of 0.02,
and a crossover rate of 0.8 [62].
Results and Discussion
In recent work, the stoichiometry and binding affinity
of NC for hairpin SL2, SL3, and SL4 of HIV-1 -RNA
(Scheme 1) were determined directly by ESI-FTMS [63].
Using the same approach, aminoglycosidic antibiotics
were later found capable of forming stable noncovalent
complexes with all three RNA constructs in the absence
of NC, but their effects on the corresponding protein-
RNA assemblies were shown to be remarkably different
[12]. In fact, addition of the aminoglycoside neomycin B
(NB, Scheme 2) to preformed complexes in solution
induced the dissociation of NC·SL4 and NC·SL3, while
NC·SL2 was not affected under the same experimental
conditions. We proposed that aminoglycosides may
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Figure 1. SORI-CID and fragmentation pattern
precursors were quintuply charged anions wit
d-H2O and y-series ions were observed for SL3 (o
Fragment ions containing bound ligand were la
displayed protection of the G7:G10 sequence, cor
5= side of the secondary structure.compete with NC for binding to unique structuralfeatures of the different stemloops. The 3D structures of
the RNA hairpins [64 – 66] and the NC complexes with
SL2 and SL3 [67, 68] provided helpful indications on the
possible sites of such competition. However, in the
absence of direct structural information for the amino-
glycoside-stemloop complexes, alternative approaches
were explored to identify the location of the drug
binding sites on the different RNA constructs.
Tandem Mass Spectrometry of Aminoglycoside-
Stemloop Complexes
The effects of aminoglycoside complexation on the
gas-phase fragmentation of the stemloop structures
were investigated by comparing the results provided by
SORI-CID of free and bound RNA samples. The initial
substrates produced typical d-H2O (also described as c)
and y series expected from this type of nucleic acid [42,
51, 69, 70], as shown, for example, by the SL3 construct
in Figure 1a. No loss of nucleobases was observed,
consistent with the fact that cleavage of the N-glycosidic
bond in RNA is not associated with fragmentation of
the phosphodiester backbone. Additionally, the nearly
complete sequence coverage obtained under the se-
lected experimental conditions offered no evidence of
possible fragmentation inhibition that could be ascribed
to base-pairing between the stem complementary
strands.
Activation of the 1:1 complex of neomycin B with
SL3 (NB·SL3) induced no direct ligand dissociation
under the same conditions, while fragmentation of the
oligonucleotide backbone was readily detected (Figure
1b). Characteristic d-H2O and y products were ob-
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(G7:G10). The fact that this region is very well repre-
sented in the spectrum of free SL3 (see ions d7-H2O
through d9-H2O and y11 through y14 in Figure 1a)
suggests that the observed inhibition of phosphodiester
cleavage can be safely ascribed to the presence of
ligand. Furthermore, the observation that the majority
of the d-H2O and y ions from the region located 3= of the
protected stretch retained the drug, while none of those
from the 5= side did, provides strong indications that
the protection effects can be directly correlated to ligand
binding.
In analogous fashion, tandem mass spectrometry
was employed to investigate the binding of other ami-
noglycosides, such as tobramycin (TB) and paromomy-
cin (PR) (Scheme 2), which shared NB’s ability to
disrupt the NC·SL3 complex in solution. The binding
mode of this class of antibiotics relies on multiple
hydrogen bonds and electrostatic interactions, which
require the participation of basic functional groups
distributed on the flexible 2-deoxystreptamine scaffold
[10, 71, 72]. The presence of six amino groups in NB
versus only five in TB and PR (Scheme 2) was consid-
ered responsible for the lower dissociation constant
determined in solution for NB·SL3 (i.e., 4.2  0.3 M)
than for the other two complexes (i.e., 38.7  3.7 M
and 37.7  1.3 M, respectively) [12]. However, no
significant differences could be noted among the frag-
mentation patterns produced by the aminoglycoside
complexes under similar SORI-CID conditions (not
shown). In fact, the ion series obtained from TB·SL3 and
PR·SL3 presented the same coverage gap observed for
NB·SL3, while only small and inconclusive variations of
ligand retention were exhibited by the fragment ions.
These results are consistent with the rather diffuse
nature of the aminoglycosides binding mode that uti-
lizes several points of contact with the substrate to
achieve effective binding. Therefore, tandem experi-
ments are expected to highlight a series of nucleotides
in the construct sequence, which are part of a wider
surface involved in ligand binding. The fact that all
three aminoglycosides in the study appeared to protect
the same G7:G10 region confirms the presence of a
unique high-affinity site on this stemloop, the bound-
aries of which may be delimited by these and spatially
contiguous bases in the construct secondary structure.
Effects of Binding Mode on Gas-Phase Dissociation
The correlation between binding mode and gas-phase
behavior was further investigated using alternative
ligand-stemloop assemblies that did not involve signif-
icant electrostatic interactions. The intercalator
ethidium bromide (ET) was selected for its ability to
insert between GC base pairs and induce effective
stacking of the planar aromatic systems [73, 74]. The
groove-binder distamycin A (DA) was chosen for its
reliance on specific H-bonding interactions that are
sensitive to perturbations of the minor groove size andgeometry [75]. Following SORI-CID, the 1:1 complexes
of SL3 with ET and DA provided backbone fragmenta-
tion in addition to prominent ligand dissociation (not
shown). No gaps in the respective ion series or drug-
retaining products were noted, which would have re-
vealed the position of the binding sites. In subsequent
experiments, the power of the off-resonant pulse was
progressively reduced in an attempt to limit ligand
dissociation and highlight its protection effects (see the
Experimental section). Even upon significant reduction
of the applied power, ET·SL3 and DA·SL3 still dissoci-
ated to generate free SL3, while NB·SL3 remained
nearly completely intact (Figure 2), thus suggesting a
NB·SL3  ET·SL3  DA·SL3 gas-phase stability scale
under the selected activation conditions. These results
are in striking contrast with the solution dissociation
constants determined by titration experiments, corre-
sponding to 1.9  0.2 M for ET·SL3, 4.2  0.3 M for
NB·SL3, and 28.5  4.7 M for DA·SL3 [12]. The drastic
drop of ET·SL3 in the stability scale could be explained
by the entropic penalty associated with desolvation,
which is expected to be sizeable for intercalating inter-
actions. More significantly, the SORI-CID process itself
could be affecting the structural features of the RNA
substrate, which sustain the actual intercalation and
groove binding. This explanation would involve the
dissociation of the base pairs in the hairpin double-
stranded stem, in analogy with the melting of duplex
oligonucleotides observed under different collisional
activation [76, 77].
A duplex RNA mimicking the double-stranded stem
of SL3 (SL3D, Scheme 1) was synthesized to overcome
the fact that denaturation of a hairpin secondary struc-
ture is a mass silent process. The stable noncovalent
complexes obtained by mixing SL3D with the different
ligands were subjected to SORI-CID at the lower power
described above. Unlike equivalent complexes of the
stemloop construct, ET·SL3D and DA·SL3D did not
show direct ligand dissociation to regenerate intact
SL3D, but instead produced ions corresponding to the
individual strands with no retention of ligand (Figure
3a and b). The NB·SL3D complex did not show direct
ligand release either, but NB was found to remain
associated to the melted strands with a preference for
the 5=-oligonucleotide (Figure 3c). The absence of un-
bound intact SL3D in any of these spectra provides
strong support to the suggested connection between
strand melting and ligand dissociation. In fact, denatur-
ation is a very effective way to eliminate the base-
pairing and helical structure necessary for intercalation
and minor groove binding. In the case of aminoglyco-
sides, the strong electrostatic component of their bind-
ing mode can overcome the loss of structural context
and preserve their association with the single-stranded
products.
Applied to the stemloop assemblies, this mechanism
would involve dissociation of base pairs and defolding
of the RNA secondary structure, which would alterna-
tively result in the release of intercalators and groove
1406 TURNER ET AL. J Am Soc Mass Spectrom 2006, 17, 1401–1411binders, or retention of aminoglycosides by the single-
stranded sequences that were originally part of the
stem. In support of this explanation, the preferential
association of NB with the 5= moiety of the linearized
hairpin sequence (Figure 1b) was in excellent agreement
with the asymmetric results provided by the melting of
the NB·SL3D assembly, in which NB was found to
remain preferentially bound to the 5= strand (Figure 3c).
The greater number of Gs in this region is likely to be
the cause for the asymmetric dissociation based on the
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the electrostatic character of aminoglycoside binding. It
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context, that information provided by backbone frag-
mentation could be effectively used to map the position
of the aminoglycoside sites. Further investigations will
be necessary to elucidate the complex interplay be-
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tion effects.
Structural Determinants of Aminoglycoside
Binding
Tandem mass spectrometry was employed to investi-
gate the binding of aminoglycosides with the other
-RNA stemloops, SL2, and SL4. Coverage gaps in the
fragment ion series produced by these complexes,
which were not observed in the spectra of their respec-
tive unbound substrates, were used to identify the
regions of ligand interaction as described above. The
locations inferred from SORI-CID experiments were
compared with those obtained from simulations in
which NB was docked in different positions of the
stemloop structures and the stability of the resulting
complexes was scored according to estimations of bind-
ing free-energy provided by different algorithms in-
cluded in Autodock 3.0 [62].
In the case of NB·SL2 (Figure 4a), the protected
U14:C16 sequence included two nucleotides that
were part of a base-triple platform located in the
middle of the double-stranded stem [64]. Base mis-
matches in the stemloop helical region introduce a
kink that situates the nucleobase of U14 on the same
plane with those of A5 and A15 to complete the
platform structure. In addition, this arrangement
creates a highly negative area on the major groove
surface below the platform, which could establish
strong interactions with the basic aminoglycosides
(Figure 5a). This hypothesis was tested using an RNA
mutant in which the platform motif was eliminated
by A15 deletion (SL2M, Scheme 1). SORI-CID of the
~
d
1-
H
20
d
5-
H
20
d
4-
H
20
d
2-
H
20
d
3-
H
20
d
6-
H
20
G G C G A C U G G
R
el
at
iv
e 
In
te
n
si
ty
• •
5
~
G G C G A C U G G
d
1-
H
20
d
5-
H
20d
4-
H
20
d
2-
H
20
d
3-
H
20
R
el
at
iv
e 
In
te
n
si
ty
5
008004
y2
y2
y3
y3 y6y5
y7
• • •
• • •
Figure 4. SORI-CID and fragmentation patter
precursors were quintuply charged anions with
containing bound ligand were labeled with a dot
below the base-triple platform on the 3= stem. T
stem and loop region on the 5= side of the seconNB·SL2M complex showed a dramatic shift in theprotection profile, which pointed toward the C6:U10
region as the new putative site (Figure 4b). Consid-
ering that this mutant presented an approximate 50%
decrease of the solution-phase affinity for NB, as
shown by previous competitive binding experiments
[12], these results strongly support the platform motif
as the location of the high-affinity site on the wild-
type SL2 structure (Figure 5a). Further support was
provided by the fact that the complex with NB bound
below the platform consistently provided the lowest esti-
mates of binding free-energy among the different struc-
tures obtained by the docking simulations (Figure 5a).
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protected from fragmentation is situated between two
structurally significant motifs [66]. The first is the
GAGA tetraloop that adopts the classic GNRA-type
fold (R  purine, N  G, C, A, or U) [79]. This structure
is characterized by extensive base stacking, which re-
duces the flexibility of the unpaired bases and adds
stability to the hairpin fold. The second motif corre-
sponds to the tandem GU wobbles found in the stem,
which involve noncanonical base-pairing interactions
that force the double-stranded stem to assume a wider
and less compact conformation [80]. This combination
creates a wider and more negative major groove, which
was clearly identified as the most ideal region for
aminoglycoside binding by the docking simulations
(Figure 5c).
Following the strategy described above, sequence
mutations were employed to systematically modify the
distinctive features of this stemloop. Construct SL4M
was prepared by replacing G5 and G15 with A, thus
eliminating the tandem wobbles and restoring a regular
A-type helix (Scheme 1). Mutant SL4A replaced all four
loop nucleotides with abasic phosphodeoxyribose spac-
ers (d), thus erasing the possibility of interactions with
nucleobases of the GNRA motif. Analyzed by SORI-
CID, the NB·SL4M assembly showed fragmentation
inhibition in the G7:A10 region (Figure 6b), which
represents a moderate extension of the putative binding
site toward the loop structure as compared to wild-type
SL4. In contrast, the NB·SL4A complex displayed pro-
tection of the G5:d9 sequence (not shown), which cor-
responds to a more pronounced extension of the site
toward the tandem wobbles motif. Competitive binding
experiments in solution provided a relative affinity
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protection G7:A10, corresponding to the upper scale of SL4  SL4A  SL4M, which clearly indicatesthat the wobbles mutations has the most significant
impact on the solution stability of NB binding. Corre-
lating the site maps with the respective affinities in
solution clearly identifies the high-affinity site with the
upper stem region of wild-type SL4, where effective
ligand interactions can be established with the wobbles
functional groups and additional stabilization can be
offered by the loop bases, as indicated also by the
docking results (Figure 5c).
The results obtained from mutant stemloops pro-
vided important information regarding the structural
determinants of aminoglycoside binding. A conse-
quence of removing the platform and wobble motifs
was the creation of hairpin structures that included
regular A-helical stems analogous to that of SL3 [65].
The fact that the putative sites on SL2M, SL4M, and
SL3 were all localized at the boundary between upper
stem and loop is not coincidental, and should be
ascribed to the high structural homology presented
by these constructs. Not surprisingly, these samples
provided very similar affinities toward NB in com-
petitive binding experiments in solution [12]. As
shown by the electrostatic surface of SL3 (Figure 5b),
this region presents many opportunities for interac-
tions with positively charged aminoglycosides. In
addition, the flexibility of the loop and aminoglyco-
side backbones is expected to facilitate the position-
ing of the respective functional groups to maximize
the binding interactions. Consistent with these obser-
vations, the docking experiments provided several
alternative structures within a relatively narrow
range of estimated binding energies. In SL4, the
position of the GU wobbles has minimal effects on the
actual site location, which remains situated at the
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favorable to aminoglycoside binding (Figure 5c). The
vicinity of the loop structures enables further stabili-
zation, which contributes to the highest solution
affinity among the wild-type stemloops. In SL2, the
base-triple platform motif offers an excellent negative
surface for aminoglycoside binding (Figure 5a). How-
ever, its location in the stem midsection precludes
any additional stabilization from loop interactions,
which results in an intermediate binding affinity
among the stemloops [12].
Conclusions
The noncovalent binding of aminoglycosides with
stemloop substrates produces localized inhibitory ef-
fects on the normal backbone fragmentation of the RNA
strand by SORI-CID. The gap in sequence coverage
provided by the characteristic ion series identifies
stretches of nucleotides that are part of the aminogly-
coside binding site. In covalent adducts, the contacts
between substrates and modifiers are clearly defined by
permanent covalent bonds. Therefore, the position of
modified bases can be unambiguously revealed by
tandem mass spectrometry. In contrast, noncovalent
adducts involve interactions that may not be as nar-
rowly localized, but may be rather diffuse in nature.
Therefore, tandem mass spectrometry is expected to
point toward a range of nucleotides within the substrate
sequence and some knowledge of the substrate second-
ary structure may still be necessary to complete the
picture. Aminoglycoside binding relies on multiple
noncovalent contacts with different functional groups
on the RNA surface. The broad area corresponding to
the possible interface and the relative flexibility of the
RNA and ligand structures virtually ensure that differ-
ent populations coexist for each assembly, which
present alternative combinations of contacts within the
specific site. The ability to obtain this type of informa-
tion is highly dependent on the binding mode of the
ligand under investigation, which has to withstand at
least in part to the denaturing effects of collisional
activation on the ligand-substrate assembly. The mech-
anism by which the binding interactions translate into
fragmentation protection will be the object of future
study.
The maps obtained for the different stemloops are
consistent with the results of docking simulations and
with the binding properties revealed by prior investi-
gations. The high-affinity site of SL3 has been shown to
span the boundary between the double-stranded stem
and the single-stranded loop, in a location shared by
mutant stemloops that lack of structural features dis-
rupting their A-helical stems. The regular geometry of
the upper stem is affected by the presence of the tandem
wobbles in SL4. Rather than displacing the site away
from the loop, this motif provides an excellent surface
for aminoglycoside binding, which is still within reach
of the loop structures. The combined effects result in adramatic increase of the stemloop affinity toward ami-
noglycosides. More significantly, it is important to note
that the site position in SL3 and SL4 falls within the
larger region occupied by the NC protein in the NC·SL3
[68] and possibly NC·SL4 complex, for which there is no
high-resolution structure. The extensive overlap be-
tween the antibiotic site and the protein footprint on
these RNA domains provides the basis for a competi-
tion mechanism that could explain the aminoglycoside
inhibition of these NC-stemloop assemblies. In contrast,
the location of the aminoglycoside site beneath the
platform motif in SL2 enables only a marginal overlap
with the protein position in NC·SL2 [67] and is consis-
tent with the inability of the antibiotics to disrupt this
assembly. Future work will focus on studying the
effects of aminoglycoside antibiotics and other small
molecule ligands on the interactions between NC and
the full length -RNA to support the development of
new antiviral strategies. This investigation will also
offer the opportunity to test the applicability of the
method to larger RNA structures that may include
multiple sites and in which divalent metals (i.e., Mg2	 )
may contribute directly or indirectly to shape the bind-
ing sites.
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